The annual Benefits & Pension Summit, which was hosted virtually on June 1, is the only Benefits Canada event that brings together health benefits and capital accumulation plans in one event. This year, delegates heard the results of Benefits Canada‘s exclusive CAP Member Survey with a panel of experts discussing the findings, case studies from two leading […]
Three main drug categories — diabetes, asthma and stimulants for attention deficit hyperactivity disorder — accounted for rising drug claims in 2022, according to Lavina Viegas, Telus Health’s director of client account management, speaking during Benefits Canada‘s 2023 Benefits & Pension Summit in June. Referring to Telus Health’s 2023 drug plan trends report, she said […]
Toyota Motor Manufacturing Canada Inc. is providing employees and their dependants with $10,000 in lifetime gender affirmation coverage. The additional coverage complements existing benefits that support transitioning employees, including prescription drug coverage for hormone therapy, mental-health coverage, disability insurance and medical leaves for employees who are recovering from surgeries. The new coverage is also extended to […]
It has been called “the change.” Menopause. That time, occurring roughly between the ages of 45 and 55, when a female’s reproductive life ends and any number of incapacitating symptoms appear. These symptoms — from hot flashes to memory issues to muscle and joint pain — can impact physical health, mental health and, inevitably, performance […]
Benefits Canada is extending the deadline for entering the 2023 Workplace Benefits Awards to Friday, July 7 at 5 p.m. EST. The original industry awards program has been recognizing employers and plan sponsors for more than 20 years, highlighting their innovative approaches to supporting the mental, physical and financial well-being of their employees. Enter the 2023 Workplace Benefits […]
Specialty drugs are accounting for a slightly smaller portion of the total eligible amount for all drug claims, declining from 33.6 per cent in 2021 to 33.1 per cent in 2022, according to Telus Health’s annual drug trends report. The report, based on claims data from more than 4.6 million plan members in 2022, found the […]
While half (51 per cent) of peri- and post-menopausal U.S. women say menopause has negatively impacted their work life, just 14 per cent believe their employer recognizes the need for menopause-specific benefits, according to a new survey by Bank of America Corp. and the National Menopause Foundation. The survey, which polled more than 500 employers […]
Over the past three years, employers around the globe have been facing unprecedented levels of change, driving innovative thinking as they transform their workplace policies and programs to meet the evolving needs of employees. Is your organization at the forefront of this change? Are you stepping up your financial wellness initiatives to help employees through […]
An article on two upcoming executive departures at the Ontario Pension Board was the most-read story on BenefitsCanada.com over the last week. Here are the five most popular news stories of the week: 1. Ontario Pension Board preparing for departure of two top executives 2. Communication, education key to smooth transition to biosimilars: expert 3. 71% of Canadian employees […]
With Yukon implementing a transitioning policy on April 3 to expand the use of biosimilar medicines in its public drug plan, it’s important for benefits plan sponsors that create a similar policy for their workplace plans to be clear in their communication and education with employees. “It’s never easy to switch a medication, especially when […]